Annexin Pharmaceuticals' IPO

Annexin Pharmaceuticals raised a round of funding on April 19, 2017. Investors include Public.

Annexin Pharmaceuticals (NASDAQ Stockholm: ANNX) is a biotechnology company developing treatments for vascular diseases with damage and inflammations. The company's drug candidate, ANXV, is a human pr…

Articles about Annexin Pharmaceuticals' IPO: